-transparent.png){kind=logo}
(S)-9-(2,3-Dihydroxypropyl)adenine, a novel nucleoside analog, the sugar moiety of which is replaced by an aliphatic chain, inhibits the replication in vitro of several DNA and RNA viruses, including vaccinia, herpes simplex (types 1 and 2), measles, and vesicular stomatitis. It is also effective in vivo in reducing the mortality rate of mice inoculated intranasally with vesicular stomatitis virus.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
E DE Clercq, and
J Descamps, and
P DE Somer, and
A Holyacute
May 1983,
Acta virologica,
E DE Clercq, and
J Descamps, and
P DE Somer, and
A Holyacute
July 1981,
Toxicology and applied pharmacology,
E DE Clercq, and
J Descamps, and
P DE Somer, and
A Holyacute
October 1984,
Bioorganicheskaia khimiia,
E DE Clercq, and
J Descamps, and
P DE Somer, and
A Holyacute
August 1981,
Biochemical pharmacology,
E DE Clercq, and
J Descamps, and
P DE Somer, and
A Holyacute
December 1981,
Teratology,
E DE Clercq, and
J Descamps, and
P DE Somer, and
A Holyacute
March 1983,
Acta virologica,
E DE Clercq, and
J Descamps, and
P DE Somer, and
A Holyacute
October 1987,
Antimicrobial agents and chemotherapy,
E DE Clercq, and
J Descamps, and
P DE Somer, and
A Holyacute
December 1980,
Nucleic acids research,
E DE Clercq, and
J Descamps, and
P DE Somer, and
A Holyacute
December 1980,
Acta virologica,
E DE Clercq, and
J Descamps, and
P DE Somer, and
A Holyacute
January 1980,
Chemotherapy,
